Golzar Mobayen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Golzar Mobayen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Alain Chion
Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
1 shared publicationAna Ignat
Department of Immunology and Inflammation, Centre for Haematology, Imperial College, London, United Kingdom
1 shared publicationFan Gong
Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA
1 shared publication- Manfred Frick
Institute of General Physiology, Ulm University, Ulm, Germany
1 shared publication Michael Appiah
Department of Immunology and Inflammation, Centre for Haematology, Imperial College, London, United Kingdom
1 shared publication- Omid Seidizadeh
Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 12 June 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (12) , 4334-4346
Identification of missense variants in the C-domains of von Willebrand factor that cause gain-of-function–like activity
Recently characterized mutations Phe2561Tyr, Pro2555Arg in the von Willebrand factor (VWF) C4 domain, and Gly2705Arg in the C6 domain reportedly confer gain-of-function–like activity on the molecule, increasing responsiveness to shear stress, resulting in enhanced platelet capture. This implies that the C-terminal stem, comprised of the D4-C6 domains, plays a crucial role in modulating VWF function. To further investigate this, we used site-directed mutagenesis to generate a panel of uncharacterized C-domain variants. VWF expression and function were analyzed under static and shear stress conditions, and the biophysical properties of the variants were characterized by single-molecule optical tweezers (OT), and atomic force microscopy (AFM) imaging. All the expressed variants exhibited normal function in static assays, except the C1 domain Arg2287Trp variant that demonstrated increased binding to GPIbα. Under flow conditions at 1500 per second, all the variants had normal VWF-mediated platelet capture to collagen; however, at 5000 per second Arg2287Trp demonstrated enhanced platelet capture, whereas Asn2636Tyr (C5 domain), Thr2647Met (C6 domain), and Gly2705Arg showed reduced activity. Further analysis of the formation of rolling VWF-platelet aggregates over a VWF surface demonstrated an enhanced response to shear stress for the Arg2287Trp and Arg2384Trp (C2 domain) variants. OT analysis identified novel extension events exclusive to the C-terminal domains and more frequent unfolding events and longer unfolding extensions for Arg2287Trp and Arg2384Trp, consistent with increased flexibility and stem opening. AFM imaging confirmed that both variants favored the open stem conformation. Together, we demonstrate that mutations in the C1 and C2 domains alter stem dynamics, rendering VWF more responsive to shear stress.
- 12 June 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (12) , 4334-4346
Open AccessIdentification of missense variants in the C-domains of von Willebrand factor that cause gain-of-function–like activity
Recently characterized mutations Phe2561Tyr, Pro2555Arg in the von Willebrand factor (VWF) C4 domain, and Gly2705Arg in the C6 domain reportedly confer gain-of-function–like activity on the molecule, increasing responsiveness to shear stress, resulting in enhanced platelet capture. This implies that the C-terminal stem, comprised of the D4-C6 domains, plays a crucial role in modulating VWF function. To further investigate this, we used site-directed mutagenesis to generate a panel of uncharacterized C-domain variants. VWF expression and function were analyzed under static and shear stress conditions, and the biophysical properties of the variants were characterized by single-molecule optical tweezers (OT), and atomic force microscopy (AFM) imaging. All the expressed variants exhibited normal function in static assays, except the C1 domain Arg2287Trp variant that demonstrated increased binding to GPIbα. Under flow conditions at 1500 per second, all the variants had normal VWF-mediated platelet capture to collagen; however, at 5000 per second Arg2287Trp demonstrated enhanced platelet capture, whereas Asn2636Tyr (C5 domain), Thr2647Met (C6 domain), and Gly2705Arg showed reduced activity. Further analysis of the formation of rolling VWF-platelet aggregates over a VWF surface demonstrated an enhanced response to shear stress for the Arg2287Trp and Arg2384Trp (C2 domain) variants. OT analysis identified novel extension events exclusive to the C-terminal domains and more frequent unfolding events and longer unfolding extensions for Arg2287Trp and Arg2384Trp, consistent with increased flexibility and stem opening. AFM imaging confirmed that both variants favored the open stem conformation. Together, we demonstrate that mutations in the C1 and C2 domains alter stem dynamics, rendering VWF more responsive to shear stress.
- Open Access
- 10 September 2024
- Published by American Society of Hematology in Blood Advances
- Vol. 8 (17) , 4714-4726
Myosin-1C augments endothelial secretion of von Willebrand factor by linking contractile actomyosin machinery to the plasma membrane
Blood endothelial cells control the hemostatic and inflammatory response by secreting von Willebrand factor (VWF) and P-selectin from storage organelles called Weibel-Palade bodies (WPBs). Actin-associated motor proteins regulate this secretory pathway at multiple points. Before fusion, myosin Va forms a complex that anchors WPBs to peripheral actin structures, allowing for the maturation of content. After fusion, an actomyosin ring/coat is recruited and compresses the WPB to forcibly expel the largest VWF multimers. Here, we provide, to our knowledge, the first evidence for the involvement of class I myosins during regulated VWF secretion. We show that the unconventional myosin-1C (Myo1c) is recruited after fusion via its pleckstrin homology domain in an actin-independent process. This provides a link between the actin ring and phosphatidylinositol 4,5-bisphosphate (PIP2) at the membrane of the fused organelle and is necessary to ensure maximal VWF secretion. This is an active process requiring Myo1c ATPase activity because inhibition of class I myosins using the inhibitor pentachloropseudilin or expression of an ATPase-deficient Myo1c rigor mutant perturbs the expulsion of VWF and alters the kinetics of the exocytic actin ring. These data offer a novel insight into the control of an essential physiological process and provide a new way in which it can be regulated.
- 10 September 2024
- Published by American Society of Hematology in Blood Advances
- Vol. 8 (17) , 4714-4726
Open AccessMyosin-1C augments endothelial secretion of von Willebrand factor by linking contractile actomyosin machinery to the plasma membrane
Blood endothelial cells control the hemostatic and inflammatory response by secreting von Willebrand factor (VWF) and P-selectin from storage organelles called Weibel-Palade bodies (WPBs). Actin-associated motor proteins regulate this secretory pathway at multiple points. Before fusion, myosin Va forms a complex that anchors WPBs to peripheral actin structures, allowing for the maturation of content. After fusion, an actomyosin ring/coat is recruited and compresses the WPB to forcibly expel the largest VWF multimers. Here, we provide, to our knowledge, the first evidence for the involvement of class I myosins during regulated VWF secretion. We show that the unconventional myosin-1C (Myo1c) is recruited after fusion via its pleckstrin homology domain in an actin-independent process. This provides a link between the actin ring and phosphatidylinositol 4,5-bisphosphate (PIP2) at the membrane of the fused organelle and is necessary to ensure maximal VWF secretion. This is an active process requiring Myo1c ATPase activity because inhibition of class I myosins using the inhibitor pentachloropseudilin or expression of an ATPase-deficient Myo1c rigor mutant perturbs the expulsion of VWF and alters the kinetics of the exocytic actin ring. These data offer a novel insight into the control of an essential physiological process and provide a new way in which it can be regulated.